WhatsApp and atopic dermatitis: a clinical trial

WhatsApp and atopic dermatitis: a clinical trial

Objective: To evaluate the effect of text messages with information about atopic dermatitis (AD) on the quality of life (QoL) of children and their caregivers and on the severity of the disease. Methods: Researcher-blinded randomized controlled clinical trial. The experimental group (EG) received me...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thaís Braga Cerqueira, Renata Robl Imoto, Mariana Muzzolon, Vânia Oliveira de Carvalho
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Jornal de Pediatria
Subjects:	Atopic dermatitis Health education Quality of life Pediatrics Text message
Online Access:	http://www.sciencedirect.com/science/article/pii/S0021755724000901
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years
by: Andreas Wollenberg, et al.
Published: (2024-12-01)

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

Modern treatment methods in atopic dermatitis - literature overview
by: Martyna Borowska-Łygan, et al.
Published: (2025-01-01)

Mistakes in the diagnosis and treatment of atopic dermatitis
by: Monika Marko, et al.
Published: (2024-02-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Atopic dermatitis - the review
by: Joanna Wrona, et al.
Published: (2025-01-01)

Correlation of serum Vitamin D levels and disease severity in patients with atopic dermatitis: A hospital-based, cross-sectional study from North India
by: Shreya Malhan, et al.
Published: (2024-12-01)

Unmet needs in atopic dermatitis management: an expert consensus
by: Annalisa Patrizi, et al.
Published: (2022-07-01)

Multimorbidity in adult patients diagnosed with atopic dermatitis
by: Szymon Mućka, et al.
Published: (2025-01-01)

Determining atopic dermatitis adult patients’ preferences regarding novel systemic treatment
by: Monika Suszynska, et al.
Published: (2025-01-01)

Allergen immunotherapy in atopic dermatitis
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-08-01)

Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index
by: Gabriele Di Lorenzo, et al.
Published: (2003-01-01)

Exploring Social Health in Patients with Atopic Dermatitis: An Observational, Cross-sectional, Questionnaire Based Study on Social Participation and Emotional Support
by: Esmé Kamphuis, et al.
Published: (2025-01-01)

Efficacy of dupilumab with concomitant topical calcineurin inhibitors treatment for preschool children with atopic dermatitis: a retrospective cohort study
by: Wu Liming, et al.
Published: (2025-12-01)

Comparative study of mouse models of atopic dermatitis
by: Siqi Ye, et al.
Published: (2025-01-01)

The role of exogenous histamine in atopic dermatitis flare-ups
by: Zofia Kowalska, et al.
Published: (2024-08-01)

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01)

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
by: Marjolein de Bruin-Weller, et al.
Published: (2022-07-01)

Associations of Atopic Dermatitis in Late Adolescence with Occupation, Mental Health, Income from Work and Marital Status: A National Longitudinal Study
by: Grigorios Theodosiou, et al.
Published: (2025-01-01)

Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
by: Ahmad Vafaeian, et al.
Published: (2025-02-01)

The economic burden of atopic dermatitis in Romania: a broad perspective
by: Alin Codruț Nicolescu, et al.
Published: (2025-01-01)

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01)

Skin microbiota: pathogenic roles and implications in atopic dermatitis
by: Cong Huang, et al.
Published: (2025-01-01)

A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries
by: Amani Alfalasi, et al.
Published: (2025-12-01)

The Association between Atopic Dermatitis Severity and Mood Disturbance among Adults: A Cross-sectional Study
by: Farah F. Albakr, et al.
Published: (2024-12-01)

A Study on the Classification of Atopic Dermatitis by Spectral Features of Hyperspectral Imaging
by: Eun Bin Kim, et al.
Published: (2025-01-01)

Atopic dermatitis in childhood and pubertal development: A nationwide cohort studyCapsule Summary
by: Camilla Lomholt Kjersgaard, MD, et al.
Published: (2025-04-01)

COVID-19 related epigenetic changes and atopic dermatitis: An exploratory analysis
by: Zhenwei Tang, MD, et al.
Published: (2025-01-01)

The epidermal lipid-microbiome loop and immunity: Important players in atopic dermatitis
by: Junchao Wu, et al.
Published: (2025-02-01)

Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
by: Filip Rob, et al.
Published: (2025-12-01)

A Cross-sectional Study to Assess the Association of Minor Criteria of Hannifin and Rajka with Age and Gender in Pediatric Atopic Dermatitis Population
by: Garima Bansal, et al.
Published: (2024-12-01)

Atopic Dermatitis And Intercourse Difficulties : A Cross-sectional Study of the Northern Finland Birth Cohort 1966 Study
by: Atte Sopenlehto, et al.
Published: (2025-01-01)

Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis
by: Verónica Sánchez-García, et al.
Published: (2025-02-01)

Asthma and Atopic Diseases in Children with Autism Spectrum Disorders
by: Khaled Saad, et al.
Published: (2024-12-01)

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
by: Liu J, et al.
Published: (2025-02-01)

Gut microbiota and plasma metabolites in pregnant mothers and infant atopic dermatitis: A multi-omics studyKey Message
by: Bingqian Du, MA.Sc, et al.
Published: (2025-01-01)

Case Report: Severe ophiasis-pattern alopecia areata with concomitant atopic dermatitis in a 5-year-old boy successfully treated with dupilumab
by: Zhendong Wei, et al.
Published: (2025-02-01)

Restorative effects of camellia oil on the skin-barrier function in a model of DNCB-induced atopic dermatitis
by: Shicheng Jiao, et al.
Published: (2025-01-01)

Patterns of Addiction in Chronic Skin Diseases: A Comparative Analysis of Addictions and Influencing Factors in Atopic Dermatitis and Psoriasis
by: Roxana Mazilu, et al.
Published: (2025-01-01)

Based on network pharmacology and molecular docking to study the mechanisms of active ingredients of ginseng in the treatment of atopic dermatitis
by: BU Jialiang, et al.
Published: (2025-01-01)